Medication info

Metmaril SR Tablet 2/500 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated triple tablet
Packaging
30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201503637 · Approved 2015.06.08 · Insurance code 645404470

This product's status changed to Approval withdrawn on 2025.07.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes
Who takes it
Adults
Adult dose
The dose of antidiabetic agents should be adjusted according to each patient's blood glucose level. Refer to the following when initiating this medicine, and start at the lowest possible dose. 1) When blood glucose is not adequately controlled with sulfonylurea or metformin monotherapy: The usual initial dose is 2/500mg of glimepiride/metformin hydrochloride per day, and the dose may be adjusted considering the patient's current medications and blood glucose levels. If a long-acting sulfonylurea (e.g., chlorpropamide) was used before starting this medicine, carefully monitor the patient to avoid hypoglycemia due to excessive pharmacologic effects. 2) When used as a replacement for combination therapy: Administer the same dose as the existing daily doses of glimepiride and metformin hydrochloride. If necessary, increase the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of glimepiride 8mg and metformin 2000mg; appropriate blood glucose monitoring should be performed. Glimepiride generally provides little additional effect at doses above 4mg, although some patients have shown better metabolic control when the dose was increased to 6mg (or 8mg). Administer this medicine once daily before or with breakfast or the main meal. If a dose is missed, do not take more than a single dose at the next administration. This is an extended-release formulation; swallow it whole without crushing or chewing. (See General Precautions)

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes

View approved original text

This medication is used to effectively assist blood sugar control in patients with type 2 diabetes by complementing dietary and exercise therapy. The combination of glymeperide and metformin improves blood glucose levels and contributes to the patient's diabetes management.

How to take

Adult dose

The dose of antidiabetic agents should be adjusted according to each patient's blood glucose level. Refer to the following when initiating this medicine, and start at the lowest possible dose. 1) When blood glucose is not adequately controlled with sulfonylurea or metformin monotherapy: The usual initial dose is 2/500mg of glimepiride/metformin hydrochloride per day, and the dose may be adjusted considering the patient's current medications and blood glucose levels. If a long-acting sulfonylurea (e.g., chlorpropamide) was used before starting this medicine, carefully monitor the patient to avoid hypoglycemia due to excessive pharmacologic effects. 2) When used as a replacement for combination therapy: Administer the same dose as the existing daily doses of glimepiride and metformin hydrochloride. If necessary, increase the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of glimepiride 8mg and metformin 2000mg; appropriate blood glucose monitoring should be performed. Glimepiride generally provides little additional effect at doses above 4mg, although some patients have shown better metabolic control when the dose was increased to 6mg (or 8mg). Administer this medicine once daily before or with breakfast or the main meal. If a dose is missed, do not take more than a single dose at the next administration. This is an extended-release formulation; swallow it whole without crushing or chewing. (See General Precautions)

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should be temporarily discontinued if there is a rapid decline in kidney function or signs of dehydration. Additionally, it should not be administered to patients with renal function less than 45 mL/min/1.73 m², severe liver dysfunction, cardiovascular collapse, severe infections, and patients before and after surgery. At the beginning of treatment, there is a higher risk of hypoglycemia; therefore, particular caution is advised for undernourished or fasting patients, elderly patients, and those with decreased kidney function. When taking this medication, do not crush or chew the tablets, swallow them whole, and it is recommended to take it with meals as gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may occur. The medication lowers blood sugar levels, so hypoglycemic symptoms (headaches, trembling, dizziness, etc.) may occur, and if any of these symptoms appear, immediate intake of sugar or consultation with a physician is necessary. Regularly check kidney function and hematological values to ensure there are no abnormalities, and monitor vitamin B12 levels if necessary, as vitamin B12 deficiency may occur. Women who are pregnant or nursing should not take this medication, and if planning to become pregnant, it is recommended to consult a physician about switching to insulin therapy. Since this medication may interact with other drugs, patients must inform their doctor or pharmacist of any medications they are currently taking, especially those affecting kidney function or alcohol, which should be avoided. In case of overdose, severe hypoglycemia or lactic acidosis may occur, necessitating immediate medical attention for appropriate treatment. Finally, during the course of this medication, it is important to maintain a regular diet and exercise, and consistently monitor blood sugar and kidney function.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal swelling
  • bloating
  • loss of appetite
  • discomfort
  • metallic taste
Show 32 more
  • visual impairment
  • taste disorder
  • itching
  • hives
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • vitamin B12 deficiency
  • peripheral neuropathy
  • megaloblastic anemia
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorder
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity dermatitis
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency due to diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • epigastric pain
  • abdominal discomfort
  • abnormal bowel sounds
  • constipation
  • indigestion
  • hyperkalemia
  • hypertension
  • flushing

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White rectangular film-coated triple tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.